OmniAb to Participate in Three Upcoming Investor Conferences

Rhea-AI Summary

OmniAb, Inc. (NASDAQ: OABI) has announced participation in three investor conferences. The first is the SVB Securities Global Biopharma Conference from February 14-16, 2023, featuring a virtual fireside chat on February 15 at 11:20 a.m. Eastern time. Next, at the Cowen 43^rd Annual Health Care Conference from March 6-8, 2023 in Boston, management will present on March 8 at 9:50 a.m. Eastern time. Lastly, they will host one-on-one meetings at the 35^th Annual Roth Conference from March 12-14, 2023. Details of the presentations will be available on their website.

EMERYVILLE, Calif.--(BUSINESS WIRE)-- OmniAb, Inc. (NASDAQ: OABI) today announced that management will be participating in three upcoming investor conferences.

• SVB Securities Global Biopharma Conference, February 14-16, 2023. Management will be participating in a virtual fireside chat on Wednesday, February 15^th at 11:20 a.m. Eastern time and will be hosting one-on-one virtual meetings with investors.

• Cowen 43^rd Annual Health Care Conference, March 6-8, 2023 at the Boston Marriott Copley Place. Management will be presenting a corporate overview on Wednesday, March 8^th at 9:50 a.m. Eastern time and will be hosting one-on-one meetings with investors. The presentation will be webcast live and available for replay in the Investors section of OmniAb’s website by clicking here.

• 35^th Annual Roth Conference, March 12-14, 2023 at The Ritz-Carlton Laguna Niguel. Management will be hosting one-on-one meetings with investors.

About OmniAb^®
OmniAb’s discovery platform provides pharmaceutical industry partners access to diverse antibody repertoires and high-throughput screening technologies to enable discovery of next-generation therapeutics. At the heart of the OmniAb platform is the Biological Intelligence™ (BI) of our proprietary transgenic animals, including OmniRat^®, OmniChicken^® and OmniMouse^® that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. OmniFlic^® (transgenic rat) and OmniClic^® (transgenic chicken) address industry needs for bispecific antibody applications though a common light chain approach, and OmniTaur™ features unique structural attributes of cow antibodies for complex targets. We believe the OmniAb animals comprise the most diverse host systems available in the industry and they are optimally leveraged through computational antigen design and immunization methods, paired with high-throughput single B cell phenotypic screening and mining of next-generation sequencing datasets with custom algorithms to identify fully human antibodies with superior performance and developability characteristics. An established core competency focused on ion channels and transporters further differentiates our technology and creates opportunities in emerging target classes. OmniAb antibodies have been leveraged across modalities, including bispecific antibodies, antibody-drug conjugates and others. The OmniAb suite of technologies span from BI-powered repertoire generation to cutting edge antibody discovery and optimization offering a highly efficient and customizable end-to-end solution for the growing discovery needs of the global pharmaceutical industry.

For more information, please visit www.omniab.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230207005191/en/

OmniAb, Inc.

investors@OmniAb.com

Twitter @OmniAbTech

(510) 250-7801

LHA Investor Relations

Yvonne Briggs

ybriggs@lhai.com

(310) 691-7100

Source: OmniAb, Inc.

FAQ

What conferences will OmniAb (OABI) participate in February 2023?

OmniAb will participate in the SVB Securities Global Biopharma Conference from February 14-16, 2023, and host a virtual fireside chat on February 15 at 11:20 a.m. Eastern time.

When is the Cowen 43rd Annual Health Care Conference for OmniAb (OABI)?

The Cowen 43rd Annual Health Care Conference is from March 6-8, 2023, with a presentation by OmniAb on March 8 at 9:50 a.m. Eastern time.

What is the date for the 35th Annual Roth Conference involving OmniAb (OABI)?

The 35th Annual Roth Conference will take place from March 12-14, 2023, where OmniAb will host one-on-one meetings with investors.

Where can I find OmniAb's presentations from the investor conferences?

Presentations from the investor conferences will be webcast live and later available for replay in the Investors section of OmniAb's website.